<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35148438</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3083</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>36</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title>
          <ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reply to "COVID vaccine-induced lichen planus on areas previously affected by vitiligo".</ArticleTitle>
        <Pagination>
          <StartPage>e423</StartPage>
          <EndPage>e425</EndPage>
          <MedlinePgn>e423-e425</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.18001</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bularca</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0001-9043-4985</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Monte-Serrano</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-0439-1200</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villagrasa-Boli</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lapeña-Casado</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de-la-Fuente</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-6328-4958</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA>
        <NlmUniqueID>9216037</NlmUniqueID>
        <ISSNLinking>0926-9959</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e28-e30</RefSource>
          <PMID Version="1">34547122</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017496" MajorTopicYN="Y">Hypopigmentation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008010" MajorTopicYN="Y">Lichen Planus</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014820" MajorTopicYN="Y">Vitiligo</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>11</Day>
          <Hour>17</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35148438</ArticleId>
        <ArticleId IdType="pmc">PMC9114985</ArticleId>
        <ArticleId IdType="doi">10.1111/jdv.18001</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Zafar M, Ewnetu B, Ahmed S, Iqbal U, Whitehead M. COVID‐19 vaccination‐induced rash: does the choice of vaccine matter?
Cureus
2021; 13(6): e15490. 10.7759/cureus.15490
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.15490</ArticleId>
            <ArticleId IdType="pmc">PMC8262263</ArticleId>
            <ArticleId IdType="pubmed">34268022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lai YC, Yew YW. Lichen planus and lichenoid drug eruption after vaccination. Cutis
2017; 100(6): E6–E20.</Citation>
        </Reference>
        <Reference>
          <Citation>
Nogueira PA, Carneiro S, Ramos‐e‐Silva M. Oral lichen planus: an update on its pathogenesis. Int J Dermatol
2015; 54(9): 1005–1010. 10.1111/ijd.12918
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijd.12918</ArticleId>
            <ArticleId IdType="pubmed">26147778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alter G, Yu J, Liu J
et
al. Immunogenicity of Ad26.COV2.S vaccine against SARS‐CoV‐2 variants in humans. Nature
2021; 596(7871): 268–272. 10.1038/s41586-021-03681-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-021-03681-2</ArticleId>
            <ArticleId IdType="pmc">PMC8357629</ArticleId>
            <ArticleId IdType="pubmed">34107529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Troeltzsch M, Gogl M, Berndt R, Troeltzsch M. Oral lichen planus following the administration of vector‐based COVID‐19 vaccine (Ad26.COV2.S). Oral Dis
2021. 10. 10.1111/odi.14. Online ahead of print.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/odi.14</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Merhy R, Sarkis AS, Kaikati J, El Khoury L, Ghosn S, Stephan F. New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination. J Eur Acad Dermatol Venereol
2021; 35(11): e729–e730. 10.1111/jdv.17504
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17504</ArticleId>
            <ArticleId IdType="pmc">PMC8447319</ArticleId>
            <ArticleId IdType="pubmed">34236718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hiltun I, Sarriugarte J, Martínez‐de‐Espronceda I
et al. Lichen planus arising after COVID‐19 vaccination. J Eur Acad Dermatol Venereol
2021; 35(7): e414–e415. 10.1111/jdv.17221
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17221</ArticleId>
            <ArticleId IdType="pmc">PMC8250777</ArticleId>
            <ArticleId IdType="pubmed">33724563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sharda P, Mohta A, Ghiya BC, Mehta RD. Development of oral lichen planus after COVID‐19 vaccination – a rare case report. [published online ahead of print, 2021 Oct 4]. J Eur Acad Dermatol Venereol. 2022; 36(2): e82–e83. 10.1111/jdv.17718
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17718</ArticleId>
            <ArticleId IdType="pmc">PMC9088686</ArticleId>
            <ArticleId IdType="pubmed">34606669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Piccolo V, Mazzatenta C, Bassi A
et al. COVID vaccine‐induced lichen planus on areas previously affected by vitiligo. J Eur Acad Dermatol Venereol. 2022; 36(1): e28–e30. 10.1111/jdv.17687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17687</ArticleId>
            <ArticleId IdType="pmc">PMC8657361</ArticleId>
            <ArticleId IdType="pubmed">34547122</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
